Ultragenyx Pharmaceutical Inc (NAS:RARE)
$ 57.87 1.5 (2.66%) Market Cap: 5.33 Bil Enterprise Value: 4.46 Bil PE Ratio: 0 PB Ratio: 12.33 GF Score: 74/100

Ultragenyx Pharmaceutical Inc in Virtual Presentation at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 05:35PM GMT
Release Date Price: $45.35 (-7.79%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Presentation at Barclays Global Healthcare Conference
Mar 11, 2020 / 05:35PM GMT

=====================
Corporate Participants
=====================
* Shalini Sharp
Ultragenyx Pharmaceutical Inc. - Executive Officer

=====================
Conference Call Participants
=====================
* Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

=====================
-

Shalini Sharp
Ultragenyx Pharmaceutical Inc. - Executive Officer

Thank you, everyone. My name is Gena Wang. I'm a smid cap biotech analyst at the Barclays. I first hope everyone stay healthy, and I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual health care conference possible.

With that, I would like to introduce our next speaker, Shalini Sharp, Chief Financial Officer from Ultragenyx. Shalini, I'll hand over to you.

-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot